Comorbidity, metastases, and survival in women with metastatic breast cancer (mBC) receiving HER2-targeted agents (H2Ts).
Nicole Meyer
Research Funding - Truven Health Analytics
Yanni Hao
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Xue Song
Research Funding - Truven Health Analytics
William M. Johnson
Research Funding - Truven Health Analytics
Nianwen Shi
Research Funding - Truven Health Analytics
Jaqueline Willemann Rogerio
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Denise A. Yardley
No relevant relationships to disclose